Security key
87650L103
Tarsus Pharmaceuticals, Inc. - Common Stock (TARS)
CUSIP: 87650L103
Q3 2021 13F Holders as of 30 Sep 2021
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 12,869,541
- Total 13F value
- $277,366,339
- Share change
- -452,111
- SEC-reported price per share
- $21.55
- Number of holders
- 43
- Value change
- -$12,449,066
- Number of buys
- 15
- Number of sells
- 22
- Shares outstanding
- 42,282,321
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2021
Institutions
43
Top holders
10
TARS full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2021
Previous quarter: Q2 2021
Tarsus Pharmaceuticals, Inc. SEC filings
Tarsus Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 87650L103
Recent filing periods:
Ownership snapshot
Top reported holders of TARS - Tarsus Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Vivo Capital, LLC
Disclosed value leader
Vivo Capital, LLC
Comparable rows
15/15
Latest evidence
30 Jun 2021
13F
3/4/5
Lead comparable stake: 7.1%
Showing 1-6 of 15 holder rows.
Quick read
Vivo Capital, LLC leads the comparable SEC ownership view at 7.1%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Vivo Capital, LLC's linked filing trail.
Comparable ownership
Top 5
Vivo Capital, LLC
7.1%
RTW INVESTMENTS, LP
4.8%
Cormorant Asset Management, LP
3.6%
FRAZIER MANAGEMENT LLC
3.4%
PERCEPTIVE ADVISORS LLC
3.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Vivo Capital, LLC |
13F
Company
|
7.1%
|
$86,573,000
2,987,331 shares
|
— | 30 Jun 2021 |
| RTW INVESTMENTS, LP |
13F
3/4/5
Company · 10%+ Owner
|
4.8%
|
$58,354,000
2,013,601 shares
|
— | 30 Jun 2021 |
| Cormorant Asset Management, LP |
13F
Company
|
3.6%
|
$43,884,000
1,514,269 shares
|
— | 30 Jun 2021 |
| FRAZIER MANAGEMENT LLC |
13F
Company
|
3.4%
|
$41,069,000
1,417,157 shares
|
— | 30 Jun 2021 |
| PERCEPTIVE ADVISORS LLC |
13F
Company
|
3.1%
|
$37,570,000
1,296,416 shares
|
— | 30 Jun 2021 |
| TimesSquare Capital Management, LLC |
13F
Company
|
1.6%
|
$19,901,000
686,705 shares
|
— | 30 Jun 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
43
Shares
12,869,541
Rows available
43
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2021 vs Q2 2021 Across Filers
Q2 2021 holders
44
Q3 2021 holders
43
Holder diff
-1
| Investor | Q2 2021 Shares | Q3 2021 Shares | Share Diff | Share Chg % | Q2 2021 value | Q3 2021 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend